# Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/use-of-chemotherapy-plus-a-monoclonal-antibody-against-her2-for-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dennis J. Slamon,Brian Leyland‐Jones,Steven Shak,H. Fuchs,Virginia Paton,Alex Bajamonde,Thomas Fleming,W. Eiermann,Janet Wolter,Mark D. Pegram,José Baselga,Larry Norton |
| Citations | 11,555 |
| DOI | 10.1056/nejm200103153441101 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJM200103153441101?articleTools=true |
| OpenAlex ID | https://openalex.org/W2318605753 |
| PMID | 11248153 |
| Type | article |
| Year | 2001 |

## Paper authors

- [W. Eiermann](https://scholariq.org/researchers/w-eiermann/)
- [Larry Norton](https://scholariq.org/researchers/larry-norton/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.